Canada’s medical cannabis landscape is facing a profound transformation.
Since the legalization of recreational marijuana in 2018, there has been a steep decline in both patient registrations and spending. The challenge now lies in deciphering the reasons and navigating future implications.
In a recent report by Zuanic & Associates, Canada's cannabis market shows growth but lags behind the U.S. in per capita spending and market share. Meet Pablo Zuanic who will further discuss these and many more findings at the Benzinga Cannabis Capital Conference in Chicago. Save the date: September 27 and 28.
Related Content: Canada's Cannabis Market Shows Steady Growth But Lags Behind US Counterparts
Numbers Don't Lie
Recent data from Health Canada and Statistics Canada underlined this downturn. As of March, only 212,700 patients were actively registered with federal licensees, down 38% from October 2018’s 345,520.
Financial patterns echo this change, with medical cannabis expenses for the …